New Technology for the $5 Billion Dental Equipment Industry
LANTIS LASER CAN PRODUCE DENTAL IMAGES WITH 10 TIMES BETTER RESOLUTION THAN TRADITIONAL X-RAYS
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash


AGORACOM WIRE .... WEEKEND EDITION

TOP STORY .... AGORACOM Launches GraphiteStocksBlog.com

We're proud to announce the launch of GraphiteStocksBlog.com a website dedicated to the needs of investors and companies in the fast growing Graphite industry.

INAUGURAL GRAPHITE SPONSORS

 

AGORACOM INTERVIEWS ERIC SPROTT: Eric Discusses UC Resources $1.5M Investment INTO Sprott + Current And Future Silver Path

Message: agreements with universities

Generic_profile
Rank: [?]
Treasurer
Points: [?]
313
Rating: [?]
Votes: 4 Score: 3.3
  • Currently 3.3/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

agreements with universities

posted on Sep 28, 09 02:14PM

I was just going through thecompany's lastest quarterly filed last month. I didn't realize it had agreemets with univierisites in Florida and California. To have licensing agreements with Univeristies obviously shows it has something and colleges are willing to use Lantis's technology: Here is an excerpt:

University of California – San Francisco

On July 9, 2008, the Company entered an exclusive license agreement for near-infrared transillumination for the imaging of early dental decay with The Regents of the University of California. The agreement requires the payment of an initial non-refundable license fee of $10,000 and annual license fees of $5,000. The agreement also requires the payment of certain milestone payments based on patent allowance and FDA approval.

On August 4, 2009, the Company and The Regents of the University of California entered into an Amended License Agreement (Amendment No. 1) whereby milestones were updated to provide adequate time for the Company to complete development, obtain FDA clearance and transition to marketing and manufacturing.

First year of sales, or no later than 2010 $ 10,000
Second year 50,000 Third year 100,000 Fourth year 150,000 Fifth and subsequent years 200,000

Earned royalties of 5% of net sales of the product or method are required to the extent that they exceed the minimum royalties. The agreement continues in effect until terminated by the parties or the patent rights expire or are abandoned. The Company paid $5,420 in license fees ($5,000) and other patent and legal expenses ($420) in the six months ended June 30, 2009, and there are no amounts accrued for as of June 30, 2009.

New Message

Please login to post a reply

AGORACOM Quick Tips

What Is Twitter? Watch Our 5-Minute Tutorial ... Watch Now
Watch
Today's Show
in 00:00:000

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote